# A Study of LY3502970 in Participants With Impaired and Normal Liver Function

> **NCT05882032** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 29 (actual)

## Conditions studied

- Healthy
- Hepatic Insufficiency

## Interventions

- **DRUG:** LY3502970

## Key facts

- **NCT ID:** NCT05882032
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-13
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-11-18
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05882032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05882032, "A Study of LY3502970 in Participants With Impaired and Normal Liver Function". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05882032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*